Erratum to: Interactions between extracellular signal-regulated kinase 1/2 and P38 Map kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity (Journal of Bone and Mineral Research, (2012), 27, 3, (538-551), 10.1002/jbmr.561)

Readers of the Journal of Bone and Mineral Research (JBMR) have reported to the JBMR editors and to John Wiley and Sons, Inc. that there is concern regarding two figures in the above article. For the first instance, in Figure 1B of the publication,⁽¹⁾ the total Runx2 lane is partially duplicated in Figure 7B in the same publication, and labeled as total p-38. The authors have been able to locate the correct total Runx2 image to produce a corrected Figure 1, below: (Figure presented.) In the second instance, in Figure 5 of the same publication,⁽¹⁾ the total ERK lane is duplicated in Figure 5A and D. Figure 5A describes effects of ERK, MAPK, and p38 MAPK inhibitors on Runx2 phosphorylation and activity in transfected COS7 cells, whereas Figure 5C and D describe effects of these inhibitors on mineralization, Runx2 phosphorylation, and MAPK activities in mouse calvarial organ cultures. The same total ERK blot was mistakenly used for both panels. The authors have been able to locate the correct image for total ERK for Figure 5D to produce a corrected Figure 5, as shown below: (Figure presented.) The authors have confirmed that these errors do not affect the results of the work. After review of the documentation and new figures, the ASBMR Research Integrity Panel concurred with such conclusion and in concert with the Editor-in-Chief recommended that this Erratum be published. The authors regret the mistakes and apologize for any confusion this might have caused. DATA AVAILABILITY STATEMENT Not applicable. DATA AVAILABILITY STATEMENT Not applicable.